glutathione depletion autism Intranasal Intracellular and extracellular glutathione redox

10.1038/s41413-018-0039-2 74 GaoB.JiangB.XingW.XieZ.LuoZ.ZouW

2021;16: e0251067

Healthcare providers should consider this limited evidence base when making treatment decisions and should discuss these limitations with patients

Sikiric's lab in Croatia) No independent replication No competing research Raises red flags about bias Human data: ONE small retrospective study (not a randomized trial) No large-scale clinical trials No safety studies Unknown dosing Unknown side effects Recent systematic review (2024): Published in orthopaedic literature, concluded: "BPC-157 has potential based on preclinical data, but there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without publication." Reported Side Effects (From Online Users): Anonymous reports include: Injection site pain and swelling Joint pain Anxiety and panic attacks Heart palpitations Insomnia or drowsiness Fatigue and weakness Loss of appetite Depression and anhedonia (inability to feel pleasure) Note: These are anecdotal, not from clinical trials

This compression can lead to symptoms such as numbness, tingling, weakness, and pain in the hand and fingers

Tirzepatide addresses the limitations of standalone GIP therapy in diabetes by combining GIPR and GLP-1 receptor (GLP-1R) agonism, leveraging their complementary mechanisms [23]